ViaWealth’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Sell |
7,591
-2,035
| -21% | -$78.1K | 0.17% | 133 |
|
|
2025
Q1 | $373K | Sell |
9,626
-4,864
| -34% | -$188K | 0.23% | 117 |
|
|
2024
Q4 | $490K | Sell |
14,490
-4,357
| -23% | -$147K | 0.3% | 97 |
|
|
2024
Q3 | $770K | Sell |
18,847
-2,394
| -11% | -$97.9K | 0.45% | 72 |
|
|
2024
Q2 | $818K | Sell |
21,241
-994
| -4% | -$38.3K | 0.51% | 64 |
|
|
2024
Q1 | $953K | Sell |
22,235
-645
| -3% | -$27.7K | 0.6% | 51 |
|
|
2023
Q4 | $848K | Sell |
22,880
-8,100
| -26% | -$300K | 0.58% | 51 |
|
|
2023
Q3 | $1.12M | Buy |
30,980
+1,665
| +6% | +$60.4K | 0.82% | 30 |
|
|
2023
Q2 | $1.04M | Buy |
29,315
+1,725
| +6% | +$61.5K | 0.78% | 32 |
|
|
2023
Q1 | $982K | Buy |
27,590
+9,475
| +52% | +$337K | 0.78% | 33 |
|
|
2022
Q4 | $626K | Buy |
+18,115
| New | +$626K | 0.51% | 69 |
|